ACADIA PHARMACEUTICALS INC
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
ACAD | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 12830 EL CAMINO REAL, 92130 SAN DIEGO
- Website:
- https://acadia.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system (CNS) disorders and rare diseases. The company's commercial portfolio features FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. Acadia maintains a robust clinical pipeline with mid- to late-stage programs targeting unmet needs in neurological conditions, including Alzheimer's disease psychosis and Lewy body dementia psychosis. The company is committed to serving underserved patient communities by advancing novel treatments and providing comprehensive support resources for patients and their families.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ACADIA PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ACADIA PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ACADIA PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
